1. Home
  2. WLDN vs MGTX Comparison

WLDN vs MGTX Comparison

Compare WLDN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$67.85

Market Cap

1.2B

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$11.71

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
MGTX
Founded
1964
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
WLDN
MGTX
Price
$67.85
$11.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$114.50
$24.57
AVG Volume (30 Days)
257.7K
801.1K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
33.02
EPS
0.55
N/A
Revenue
$273,352,000.00
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
$12.05
N/A
P/E Ratio
$127.55
N/A
Revenue Growth
N/A
144.57
52 Week Low
$64.67
$6.62
52 Week High
$137.00
$15.35

Technical Indicators

Market Signals
Indicator
WLDN
MGTX
Relative Strength Index (RSI) 28.21 44.09
Support Level $64.67 $8.84
Resistance Level $85.06 $11.85
Average True Range (ATR) 2.73 0.65
MACD 0.08 -0.24
Stochastic Oscillator 5.20 3.45

Price Performance

Historical Comparison
WLDN
MGTX

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: